Protagonist Therapeutics, Inc. · NASDAQ:PTGX

BVF PARTNERS L P/IL reported a 5.20% stake in Protagonist Therapeutics, Inc. (Schedule 13G)

Event Jun 9, 2025 · Filed Jun 16, 2025

BVF PARTNERS L P/IL reported a 5.20% stake in Protagonist Therapeutics, Inc., 3,211,041 shares, as a passive investor on Jun 9, 2025. Filed Jun 16, 2025 (Schedule 13G).

Stake
5.20%
Shares
3,211,041
Intent
Passive
What changed
Crossed above 5%
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P2.70%1,681,652
BVF I GP LLC2.70%1,681,652
BIOTECHNOLOGY VALUE FUND II LP2.10%1,280,665
BVF II GP LLC2.10%1,280,665
Biotechnology Value Trading Fund OS LP0.30%181,190
BVF Partners OS Ltd.0.30%181,190
BVF GP HOLDINGS LLC4.80%2,962,317
BVF PARTNERS L P/IL5.20%3,211,041
BVF INC/IL5.20%3,211,041
LAMPERT MARK N5.20%3,211,041

Source

View original at SEC

Related